Personal profile
Biography
Professor Cloud holds a joint appointment as Director of Stroke Services at Alfred Health and adjunct Professor of Stroke Medicine in the Department of Neuroscience at the School of Translational Medicine. Previously he worked as a full time Consultant Stroke Physician and Honorary Senior Lecturer in the Department of Clinical Neurosciences at St George’s Hospital in London.
Professor Cloud is current chair of the Australian Stroke Data (AuSDaT) monitoring and the Australian Stroke Registry (AuSCR) quality improvement committees, and an elected council member of the Stroke Society of Australasia and New Zealand. Professor Cloud adjudicates outcomes for the ASPirin in Reducing Events in the Elderly (ASPREE) study and chairs the stroke adjudication committee for the STAtins in Reducing Events in the Elderly (STAREE).
Having been an investigator for more than 50 randomized controlled stroke trials, Professor Cloud is dedicated to researching all aspects of improving stroke care and has close collaborations with other School of Translational Medicine researchers, Professors Natasha Lannin and Robert Medcalf.
Outside of stroke service quality improvement and large clinical trials, Professor Cloud's published research interests include posterior circulation stroke, novel interventions for motor recovery after stroke and understanding the needs of stroke carers. He is co-author of the Oxford University Press Handbook of Stroke Medicine.
Research area keywords
- Stroke
- Cerebrovascular Disorders
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
Cloud, G. (Primary Chief Investigator (PCI))
28/05/25 → 27/05/27
Project: Research
-
A Double-Blind, Placebo-Controlled, Proof-of-Concept Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod on Recovery after Moderate to Severe Acute Ischaemic Stroke
Cloud, G. (Primary Chief Investigator (PCI))
12/03/25 → 11/03/27
Project: Research
-
A Phase 2b, Multinational, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared with Placebo in Adult Participants with Acute Ischemic Stroke
Cloud, G. (Primary Chief Investigator (PCI))
9/08/24 → 9/08/26
Project: Research
-
A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute noncardioembolic ischemic stroke or high-risk TIA
Cloud, G. (Primary Chief Investigator (PCI)) & Murphy, L. (Project Manager)
13/02/23 → 30/12/25
Project: Research
-
New models of rehabilitation to improve work and health outcomes after stroke
Lannin, N. (Primary Chief Investigator (PCI)), Holland, A. (Chief Investigator (CI)), Jolliffe, L. (Chief Investigator (CI)), Cloud, G. (Chief Investigator (CI)), Crotty, M. (Chief Investigator (CI)), Farrin, A. (Chief Investigator (CI)) & Wong, D. (Chief Investigator (CI))
1/01/22 → 31/12/24
Project: Research
-
Proteinopathies and the Neurodegenerative Aftermath of Stroke: Potential Biomarkers and Treatment Targets
Allen, J. (Leading Author), Ermine, C. M. (Leading Author), Lin, R., Cloud, G. C., Shultz, S. R. (Leading Author) & Casillas-Espinosa, P. M. (Leading Author), Jun 2025, In: Stroke. 56, 6, p. 1600-1611 12 p.Research output: Contribution to journal › Review Article › Research › peer-review
1 Link opens in a new tab Citation (Scopus) -
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People
Zoungas, S. (Leading Author), Moran, C. (Leading Author), Curtis, A. J., Spark, S., Flanagan, Z., Beilin, L., Chong, T. T. J., Cloud, G. C., Hopper, I., Kost, A., McNeil, J. J., Nicholls, S. J., Reid, C. M., Ryan, J., Tonkin, A. M., Ward, S., Wierzbicki, A. S., Wolfe, R., Zhou, Z. & Nelson, M. R. & 1 others, , 19 Nov 2024, In: Journal of the American Heart Association. 13, 22, 10 p., e036357.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Link opens in a new tab Citations (Scopus) -
Development, implementation, and evaluation of the Australian Stroke Data Tool (AuSDaT): Comprehensive data capturing for multiple uses
Ryan, O., Ghuliani, J., Grabsch, B., Hill, K., C Cloud, G., Breen, S., Kilkenny, M. F. & Cadilhac, D. A., May 2024, In: Health Information Management Journal. 53, 2, p. 85–93 9 p.Research output: Contribution to journal › Article › Research › peer-review
7 Link opens in a new tab Citations (Scopus) -
Hyper-Acute Stroke Systems of Care and Workflow
Kleinig, T. J., McMullan, P., Cloud, G. C., Bladin, P. C. & Ranta, A., 2024, In: Current Neurology and Neuroscience Reports. 24, p. 495–505 11 p.Research output: Contribution to journal › Review Article › Other › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Incidence of and risk factors for new-onset urinary and fecal incontinence after acute stroke
Cruz, E., Wells, Y., Miller, C., Lannin, N. A. & Cloud, G. C., Mar 2024, In: Continence. 9, 6 p., 101067.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)